• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

FibroGen - Articles and news items

Astellas logo

First patients enrolled into European Phase III programme for potential first in class oral treatment for anaemia associated with chronic kidney disease

Industry news / 18 March 2014 / Astellas

Roxadustat could change treatment of anaemia associated with CKD and remove the need for multiple injections…

AstraZeneca

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +